S17 - Movement Disorders: Ataxia and the Cerebellum

Event Time: Monday April 24, 2017 3:30 pm to 5:30 pm
Topic(s): Movement Disorders
Description: A group of abstracts covering a similar topic presented in an oral format. Presentations are eight minutes in length with four minutes of question and answer. Each session concludes with 25 minutes of a discussant bringing additional context to one or more of the abstracts.
Completion Message:
CME Credits: 2
Core Competencies:

Abstract Presenters

Start Time Pub. Title Presenter
3:30 PM 001 ATXN2 antisense therapy improves SCA2 mouse motor and Purkinje cell electrophysiological phenotypes. Daniel Scoles, PhD
Dr. Scoles has nothing to disclose.

3:42 PM 002 Fragile X Gray Zone Alleles are associated with Better Global Motor Function in an Elderly Community Population Deborah Hall, MD, PhD, FAAN
Dr. Hall has received personal compensation in an editorial capacity from the American Academy of Neurology. Dr. Hall has received research support from Neurocrine, Pfizer, and Abbvie.

3:54 PM 003 RT001 First-in Human Clinical Trial Demonstrates Safety, Favorable Pharmacokinetics, and Early Signals of Efficacy in Friedreich’s Ataxia Theresa Zesiewicz, MD, FAAN
Dr. Zesiewicz has nothing to disclose.

4:06 PM 004 Exome Sequencing Offers a Comprehensive Genetic Evaluation and High Diagnostic Rate for Ataxia-related Disorders Francisca Millan
Dr. Millan has received personal compensation for activities with GeneDx as an employee.

4:18 PM 005 EPI-743 (Alpha-tocotrienol Quinone) Demonstrates Long-Term Improvement in Neurological Function and Disease Progression in Friedreich's Ataxia Theresa Zesiewicz
Dr. Zesiewicz has nothing to disclose.

4:30 PM 006 Cerebellar Pathology in Early Onset and Late Onset Essential Tremor Sheng-Han Kuo, MD
Dr. Kuo has nothing to disclose.

4:42 PM 007 Structure-Phenotype relationships in ATP1A3 (Na,K-ATPase) diseases Kathleen J Sweadner
Dr. Sweadner has nothing to disclose.

4:54 PM 008 In vivo drug discovery for progressive supranuclear palsy using a novel zebrafish model Qing Bai
Dr. Burton has nothing to disclose.

Register Now

Related Courses